Inc. has just published its 5,000 fastest-growing private companies in America list for 2021, and XIFIN is among its ranks for the 12th time in its 24-year history. During a period of unprecedented challenges for the healthcare industry and a significant shift towards telehealth, XIFIN proved able to not only meet the technological demands of diagnostic providers facing enormous testing volume surges, but also grew its revenue by 60% in just three years. As a twelve-time honoree, XIFIN joins an exclusive group of companies that have sustained significant growth over extended periods. Only a small fraction of honorees—an estimated 3% or less—reach this level of sustained success.
We at XIFIN are honored to receive this accolade, especially since we know our success is driven by our company-wide commitment to the mission: to deliver impactful solutions that enable healthcare providers to drive out costs while maximizing value.
Never has this been more evident than this past year, undoubtedly the most trying and redefining year for our nation’s healthcare system, and for the many providers within, who continue to play a critical role in the ongoing fight against the COVID-19 pandemic. XIFIN supported diagnostic labs both when lab volumes plummeted and as they faced sky-high testing demands. As our CEO, Lâle White, explained, “Diagnostic laboratories faced testing demands never seen before while health systems were thrust into a virtual world where remote monitoring and digital health services were not only championed but required.”
White went on to say “Reflecting upon the past year and the Inc 5000 recognition, we salute the XIFIN team’s unwavering dedication to support healthcare organizations across the country at a crucial time. The role of diagnostics has never been more critical or more evident, and we strive to provide innovative technology and high-quality services that help providers accomplish their day-to-day work efficiently and engage with patients more effectively.”
This past year XIFIN developed the Lab Volume Index (LVI), its laboratory test tracker informed by payment data that makes up 20% of all COVID-19 testing claims nationwide. It became a publicly available resource by which healthcare companies and public health leaders used to validate their own data. This type of data analysis not only exemplifies the instrumental role that labs play in collecting reliable diagnostic data to aid in the ongoing fight against new COVID-19 variants but as testing has once again ticked up in recent weeks, it also signifies that continued reporting remains paramount to support public health, safety, and education.
XIFIN provides cloud-based revenue cycle management (RCM), healthcare informatics, and laboratory information systems (LIS) that help diagnostic providers better manage their business. These best-in-class solutions and services allow healthcare organizations to streamline and optimize the billing process, employ digital alternatives that increase patient engagement, and provide leaders with greater visibility into business operations. XIFIN’s continued role in enabling customers to realize greater efficiency and generate faster reimbursements when processing COVID-19 and other diagnostic tests is underscored by the company’s recently announced expansion to the East Coast and entrance into the radiology RCM services segment through the acquisition of Computerized Management Services.
Said Scott Omelianuk, editor-in-chief of Inc., “The 2021 Inc. 5000 list feels like one of the most important rosters of companies ever compiled. Building one of the fastest-growing companies in America in any year is a remarkable achievement. Building one in the crisis we’ve lived through is just plain amazing. This kind of accomplishment comes with hard work, smart pivots, great leadership, and the help of a whole lot of people.”
XIFIN Inc rankings: ranking on Inc. 5000, 12-Timers’ Club, woman-led company, software industry ranking, California and San Diego regional ranking.
Inc. 5000 complete 2021 list